ライフサイエンスコーパス: be treated with

1 In the present study, lotus roots slices were treated with 0, 5 and 10 mmol L(-1) oxalic acid and

2 All subjects were treated with 1 dose of TMP-SMZ (160 mg/800 mg) twic

3 in our elderly patients with recent AMI who were treated with 1.8 g n-3 PUFAs daily for 2 years.

4 Term decidual cell (TDC) monolayers were treated with 10(-8) mol/L estradiol +/- 10(-7) mol/

5 atostatin receptor-positive tumor xenografts were treated with (177)Lu-DOTATATE or sham-treated and c

6 Methods: Men who were treated with (177)Lu-PSMA under a compassionate-acc

7 atment activities for efficacy studies, mice were treated with 185 kBq or 277.5 kBq of (212)Pb-daratu

8 Three patients were treated with 2.3 +/- 0.6 intravitreal injections of

9 One randomly selected orbit was treated with 20 Gy of external beam therapy; sham th

10 atic castration-resistant prostate carcinoma were treated with 210 cycles of (225)Ac-PSMA-617.

11 or effective clinical management of patients being treated with (223)Ra, there is a need for radiogra

12 tients with grass pollen rhinoconjunctivitis were treated with 3 ILIT injections and an ILIT booster

13 amylose content (waxy, normal and Hylon VII) were treated with 3% OSA solution.

14 All patients were treated with 3- or 4-drug antimycobacterial therapy

15 The purified nsLTP1 was treated with 4-vinyl pyridine, and the modified prot

16 The patients were treated with 4 mg baricitinib twice daily for 2 day

17 red by digital polymerase chain reaction who were treated with 4 units of COVID-19 convalescent plasm

18 Spheroids were treated with 5-Fluorouracil for five days through c

19 Eight advanced durum-breeding lines were treated with 5-methyl-azacytidine to test the feasi

20 t decreased when BDL rats and Mdr2(-/-) mice were treated with 5HTR2A/2B/2C antagonists compared to B

21 P23H rat pups were treated with 830 nm light (180 s; 25 mW/cm(2); 4.5

22 rvival of mice with lung adenocarcinoma that are treated with a senescence-inducing combination of dr

23 ontraindications, patients with HFrEF should be treated with a beta-blocker and one of an angiotensin

24 eishmaniases are neglected diseases that can be treated with a limited drug arsenal; the development

25 aintained more often in participants who had been treated with a drug-coated balloon than in those wh

26 a drug-coated balloon than in those who had been treated with a standard balloon (82.2% [125 of 152]

27 Narcolepsy is treated with a combination of lifestyle modifications

28 Complicated pneumonia is treated with a prolonged course of intravenous antibi

29 posure, the diatom Phaeodactylum tricornutum was treated with a sublethal concentration of trans,tran

30 ated dose (MTD) was established, 21 patients were treated with a 1-hour infusion (n = 13, 8 mg/kg, on

31 ission in 25% (n = 9), and the remaining 25% were treated with a combination of various modalities in

32 Sixty extracted carious human teeth were treated with a conventional bur (CBG) or chemomecha

33 ce systemic overburden of ADMA, Tg-SwDI mice were treated with a daily dose of exogenous ADMA.

34 Mice were treated with a direct fIIa inhibitor (fIIai) or dir

35 al in patients with actionable mutations who were treated with a matched therapy versus those who wer

36 Eyes were treated with a median of 4.5 cycles of IAC (range,

37 vely obtained when the TsN- and MsN-ynamides were treated with a mixture of diorganyl diselenides (1.

38 as confirmed in human gastric organoids that were treated with a novel SMOX inhibitor.

39 gene encoding superoxide dismutase 1 (SOD1) were treated with a single intrathecal infusion of adeno

40 r endothelial growth factor, and 21 patients were treated with a steroid.

41 patients included in the study 30% (44/149) were treated with ACEI/ARB.

42 PS was treated with acetic acid and sodium bicarbonate to i

43 cTnI-G203S or age-matched wt mice were treated with active or inactive AID-TAT.

44 Nine dogs with hemophilia A were treated with adeno-associated viral (AAV) gene ther

45 r-specific G6pc-knockout (L-G6pc(-/-) ) mice were treated with adeno-associated viruses (AAVs) 2 or 8

46 reviously healthy patients with CM and PIIRS were treated with adjunctive pulse corticosteroid taper

47 Upon arrival, 126 patients were treated with adrenaline.

48 142 patients, of which 21 have been treated with amiodarone, receiving SDCT-examination

49 rate or severe ischemia on stress testing to be treated with an initial invasive strategy consisting

50 A total of 421 (48%) patients had been treated with an ACE inhibitor or ARB, while 458 (52

51 CE inhibitor or ARB, while 458 (52%) had not been treated with an ACE inhibitor or ARB.

52 r and lymphoma patients (age >=18 years) who were treated with an anthracycline in the United States

53 One hundred fifty-seven women were treated with an average of 2 doses (range, 1-6 dose

54 d intervention for a leak, of whom 275 (24%) were treated with an endoscopically placed stent.

55 Patients with peri-implantitis that were treated with an intensive treatment protocol of bi-

56 Of these, 65 were treated with anakinra and methylprednisolone and 55

57 utcomes of adult or paediatric patients that were treated with anti-CD19 CAR T cells for relapsed or

58 Mice were treated with anti-G-CSFR 24 h prior to 22-min unila

59 All patients were treated with anti-IL-6R antibody and/or IVIG, which

60 Twenty-four patients were treated with anti-vascular endothelial growth facto

61 ither treatment naive (n = 25) or previously were treated with anti-VEGF A therapy (n = 26).

62 Furthermore, Northeast patients who were treated with anti-VEGF showed a higher odds of rece

63 cal site infection following SCS implant may be treated with antibiotic therapy alone, deep infection

64 Thirty-three patients were treated with antibiotics, for a median of 425 days

65 olism and atrial fibrillation, both of which are treated with anticoagulation.

66 Twenty-seven patients with low CrAg titers were treated with antifungal therapy and 22 (81%) respon

67 ay 1, 2015, to Feb 28, 2019, 54 313 patients were treated, with approximately 1000 patients treated p

68 ncluding those with SPINK1-positive subtype, are treated with AR-antagonists.

69 2,711 (17.7%) patients were treated with artemether-lumefantrine (AL, 13 studie

70 d red blood cells to initiate infection, and were treated with artemether-lumefantrine (Study 1) or c

71 Subjects were treated with artemether-lumefantrine after developm

72 ollowing the initial growth phase, spheroids were treated with auristatin as small molecule (MMAE) or

73 from 7 medical centers in the United States were treated with axi-cel and were included in a modifie

74 Patients were treated with AZD4547, 80 mg orally twice daily unti

75 fibroblast growth factor receptor (FGFR) 1-3 were treated with AZD4547, an oral FGFR1-3 inhibitor.

76 pose no apparent risk to driving safety, can be treated with behavioral measures, such as weight loss

77 chronic obstructive pulmonary disease, which is treated with beta-adrenoceptor-agonist medications.

78 When colonoids are treated with BFT in the presence of an inhibitor of

79 All patients were treated with biguanides and/or diamidines or azoles

80 Eosinophilic esophagitis can now be treated with biologic agents that target specific imm

81 nts with chronic plaque psoriasis (n = 6501) being treated with biologic therapy and regularly follow

82 032 total patients, 3,718, 7,934, and 13,380 were treated with BMS, DES1, and DES2, respectively.

83 Men with early-stage disease should not be treated with bone-modifying agents to prevent recurre

84 When Th9 cells are treated with both calcitriol and trichostatin A (his

85 In this 2-year follow-up of eyes that were treated with both per protocol and off protocol for

86 h anti-VEGF received the same agent and 7.7% were treated with both PRP and anti-VEGF agents.

87 Melanomas harboring BRAF mutations can be treated with BRAF inhibitors (BRAFi), but responses a

88 C57BL/6 male mice were treated with broad-spectrum antibiotics for 4 weeks

89 enteropathy is ultimately identified, should be treated with budesonide.

90 Septic mice were treated with [(C2S, 3S, 4R)-1-O-(alpha-d-galactopyr

91 e gastrointestinal disorders might therefore be treated with cannabinoids.

92 es of resistant P. aeruginosa after patients were treated with carbapenems, along with the general pr

93 ZBP1-induced necroptosis in fibroblasts that were treated with caspase inhibitors or express RIPK1 wi

94 As in any substudy, these results should be treated with caution, such as the potential for false

95 the concept of voxel-based dosimetry should be treated with caution.

96 Cultured rat hippocampal neurons were treated with cerebrospinal fluid (CSF) from patient

97 Thirteen patients were treated with cetirizine and montelukast in addition

98 ent, whereas individuals with advanced NLPHL are treated with chemotherapy alone.

99 From the included studies, 85 subgroups were treated with CHOP, 76 with R-CHOP, and in four stud

100 mals all developed fever within 78 hours and were treated with ciprofloxacin (n = 27) or levofloxacin

101 erated in vivo in human blood when a patient is treated with cisplatin.

102 All patients were treated with cisplatin-based combination chemothera

103 angle glaucoma (POAG) and cataract; each eye was treated with combined phacoemulsification, ab-intern

104 g, skin, and sera, and those individuals who were treated with complement inhibitors all recovered wi

105 Mechanistically, macrophages that were treated with conditioned media (CM) from senescent

106 The area of retinal thickening on OCT was treated with confluent laser spots at individually t

107 Junin virus infection, a related virus, can be treated with convalescent-phase serum.

108 4 million annual cases in the United States) are treated with conventional excision, this surgical mo

109 Thirty-four were treated with corticosteroids (83%), 11 with an immu

110 Of these, 10 were treated with corticosteroids, and three of these pa

111 : A total of 196 patients were analyzed: 102 were treated with CPAP and 94 were treated with NIV.

112 survivors of pediatric brain tumors who had been treated with cranial radiation.

113 Ischemic retina was treated with cryoablation as necessary.

114 All patients were treated with curative-intent chemoradiotherapy (CRT

115 Patients were treated with DAAs according to the physicians' pref

116 ents with recurrent PDGFRalpha-driven glioma were treated with dasatinib and everolimus.

117 6 eyes in 25 patients were included: 16 eyes were treated with DCN and 10 with ICN.

118 All patients were treated with definitive chemoradiation (median dose

119 Rat dams were treated with Delta(9)-tetrahydrocannabinol or a syn

120 phrectomy, wild-type and CXCR6 knockout mice were treated with DOCA/salt for 3 weeks.

121 ith sexually transmitted infection syndromes were treated with doxycycline for 7 days and recalled if

122 It can be treated with drugs during the early acute phase; howe

123 dy included adult patients with msAD who had been treated with dupilumab in 16 Italian care centres.

124 Cells were treated with eicosapentaenoic acid (EPA), docosahex

125 Cells isolated from six different donors were treated with either 1,25(OH)(2) D(3) (0 to 10 nM) o

126 VK2 E6/E7), modelling the vaginal epithelium were treated with either 4 nM 17beta-estradiol (E) for s

127 inical trial in which women with PMDD (N=95) were treated with either 5 mg/day of UPA or placebo duri

128 In the first 48 hours, patients were treated with either a beta-lactam (n = 24), includi

129 luated 150 people with CSF abnormalities who were treated with either intravenous aqueous penicillin

130 iographic evidence of 2- or 3-vessel CAD who were treated with either PCI or isolated CABG from 2008

131 xperienced an episode of atrial flutter that was treated with electrical cardioversion.

132 Most patients with SMPE were treated with embolectomy (98.9% [91 of 92]), while

133 Historically, acute appendicitis was treated with emergency appendectomy.

134 tensive heart failure rat (mRen27/tetO-shIR) were treated with empagliflozin (10 mg/kg/d) or vehicle

135 and a subset of eggs from the reference site were treated with estradiol (E2) during embryonic develo

136 erior circulation large vessel occlusion who were treated with EVT and achieved SR.

137 that report only univariable methods should be treated with extreme caution due to potential confoun

138 Of the randomised patients, 107 each were treated with fingolimod and IFN beta-1a for up to 2

139 enting components found in the cell envelope were treated with FNA at 6.09 mg N/L (NO(2)(-) = 250 mg

140 All patients were treated with gemcitabine and S-1 (GS)-based chemoth

141 When Pacific white shrimp were treated with GLE-S at different concentrations (0.5

142 h RSV infection but was inhibited when BMDCs were treated with GSK J4 prior to sensitization.

143 ignon Blanc (SAB) juices (20L in triplicate) were treated with GSP at two doses, Low (7.5 g/L) and Hi

144 l attachment level (CAL): 11.16 +/- 1.81 mm) were treated with guided tissue regeneration.

145 CCL-2 synthesis was also observed when cells were treated with H(2)O(2) In vivo, high CCL-2 productio

146 th adrenal dysfunction or severe asthma that are treated with high doses of inhaled corticosteroids.

147 myeloma (MM) is a plasma-cell neoplasm that is treated with high-dose chemotherapy, autologous stem

148 31 patients admitted to the ICU, 109 (47.2%) were treated with high-flow nasal cannula and 97 (42.0%)

149 Here, microbial membranes were treated with hydrogen peroxide (H(2)O(2)) and sodiu

150 All patients were treated with hydroxychloroquine, azithromycin, and

151 A total of 193 patients and 208 eyes were treated with IAC between April 2008 and October 201

152 etinoblastoma tumors in 6 eyes of 4 patients were treated with IAC.

153 presenting with cavitary retinoblastoma who were treated with IAC.

154 Twenty-seven patients were treated with iadademstat on days 1 to 5 (5-220 ug/m

155 m patients with chronic lymphocytic leukemia being treated with ibrutinib.

156 male, mean FEV(1) was 49%, 71.6% of patients were treated with ICS, 57.2% of them had bronchiectasis,

157 on but promotes transcription when the cells are treated with IFN-gamma.

158 ue to obesity enhances tumor formation, mice were treated with IgG or anti-F4/80 antibodies to deplet

159 e non-operative treatment have traditionally been treated with immobilisation of the tendon in plaste

160 ologically confirmed stage IIIB-IV NSCLC who were treated with immune checkpoint blockade between Jun

161 Ten of 11 patients were treated with immune checkpoint inhibition at some p

162 g vs stopping 5-aminosalicylates in patients being treated with immunomodulator and/or biologic thera

163 The patient was treated with immunosuppressive therapies, with ritux

164 ruited to this prospective study, 25 of whom were treated with in vitro-expanded autologous CMV-speci

165 Twenty-nine patients were treated with infliximab.

166 diseases (IMIDs) of the joints, gut and skin are treated with inhibitors of inflammatory cytokines.

167 The mice were treated with interferon gamma (IFNgamma) intraperit

168 removal in patients with kidney failure who are treated with intermittent haemodialysis, but the eff

169 studies in patients with kidney failure who were treated with intermittent haemodialysis suggest tha

170 Patients were treated with intravitreal injections with bevacizum

171 The first group was treated with isoniazid only, while the second one wa

172 ve cases with data for analysis, 354 (83.5%) were treated with IVF at some point during their ETU adm

173 astatic TP53 hotspot mutant solid tumors who were treated with ixazomib and vorinostat (n = 59), thos

174 R6/2 and non-transgenic (NT) mice were treated with JQ1 daily from 5 to 11 weeks of age an

175 (4), TiCl(4), ZrCl(4), FeCl(3), and AlCl(3)) were treated with ketones, aldehydes, and esters.

176 d invasive mechanical ventilation, 81 (3.2%) were treated with kidney replacement therapy, and 553 (2

177 One week later, the mice were treated with L-655,708 (0.5 mg/kg), an inhibitor th

178 Overall, 64 of 204 patients (31%) were treated with LCSD alone (37 [58%] female, mean QTc

179 Patients were treated with letrozole 2.5 mg per day for 6 months

180 Positive candidates were treated with levofloxacin.

181 All patients were treated with local infiltration of corticosteroid.

182 ve individuals requiring supplemental oxygen were treated with lopinavir-ritonavir.

183 Older patients were less likely to be treated with LT versus medication (>=81 years of age

184 ytomegalovirus was multi-drug resistant, and was treated with maribarir, intravitreal and systemic in

185 The defects were treated with Matrigel (as control), DPSC, or DPSC +

186 RVD patients were treated with medical therapy (MT) and percutaneous

187 enem-resistant Enterobacteriaceae infections were treated with meropenem-vaborbactam.

188 Six hours after surgery, mice were treated with mesenchymal stromal cells IV (1 x 10 c

189 disease, TB morality and TB recurrence, when being treated with metformin.

190 CDI was treated with metronidazole in 12 children, vancomyci

191 infection with Entamoeba histolytica, which was treated with metronidazole, followed by eradication

192 Patients were included if they were treated with metronidazole or oral vancomycin and h

193 Wild-type and Mdr2(-/-) mice were treated with mismatch or H2HR vivo-morpholino by ta

194 columnar mucosa in the tubular esophagus can be treated with mucosal ablation.

195 Leprosy has been treated with multidrug therapy, which has been dist

196 Furthermore, when these astrocytes were treated with n-3 PUFAs, the cAMP antagonist, RP-cAM

197 for structure alterations in the lungs, mice were treated with N-[N-(3,5-difluorophenacetyl)-L-alanyl

198 The nAChR-expressing neuronal cells were treated with nanomolar Abeta(1-42) to gain insights

199 Gastrointestinal cancers are increasingly being treated with NAT before surgical resection.

200 analyzed: 102 were treated with CPAP and 94 were treated with NIV.

201 Methods: Seventy-two patients with NSCLC who were treated with nivolumab or pembrolizumab and had bas

202 When the cKO mice were treated with NMN, vesicle endocytosis/exocytosis wa

203 trial fibrillation after cardiac surgery who are treated with NOACs versus Warfarin.

204 A total of 3,043 (36.2%) patients were treated with OAC at some time during the study peri

205 (g/sBRCA1) or BRCA2 (g/sBRCA2) genes should be treated with olaparib.

206 Patients were treated with one to three treatment sessions.

207 Hyperthyroidism can be treated with oral antithyroid drugs, surgical thyroid

208 therapy with topical Minoxidil solution and was treated with oral eplerenone.

209 All patients were treated with oral dabrafenib 150 mg twice daily and

210 Infections were treated with oral or topical antibiotics and resolv

211 Biofilms were treated with ozonized saline solution at different

212 ixazomib and vorinostat (n = 59), those who were treated with pazopanib and vorinostat (n = 11) had

213 ents with circumscribed choroidal hemangioma were treated with PDT.

214 cribe real-life cases of adults with ALL who were treated with pediatric-inspired regimens that incor

215 Patients were treated with pembrolizumab 2 mg/kg every 3 weeks fo

216 Methods: Female MMTV-PyMT mice were treated with pexidartinib, a colony-stimulating fac

217 Forty-three percent had been treated with platin derivatives (n=100), 14% with a

218 s non-small-cell lung cancer, had previously been treated with platinum-based chemotherapy, and had a

219 The study included 452 patients, of whom 241 were treated with PPVI with the Melody valve and 211 pat

220 oma between August 2014 and January 2019 who were treated with primary IAC.

221 Stenoses were treated with primary stenting obtaining favourable

222 Two cohorts of 6 swine were treated with pulsed fields at low dose (PF(LD)) and

223 ) had PZA resistant strains and 49.7% (n=78) were treated with PZA.

224 despite only a minority (25%) of these cases were treated with QT-prolonging antimicrobials.

225 In total, 159 patients were identified, 94% were treated with R-CHOP and 44% received RT (78% in RT

226 ur patients underwent liver resection, and 1 was treated with radioembolization.

227 nutrient-deficient media, but not when cells are treated with rapamycin, the allosteric inhibitor of

228 In this study, C57 mice were treated with RCO for 34 weeks.

229 Galactosamine-LPS and in both models animals were treated with recAP prior to LPS administration.

230 Roots were treated with reflection of interproximal papillae,

231 t 86 pregnant women with severe COVID-19 who were treated with remdesivir.

232 All the patients were treated with renin-angiotensin system blockade that

233 ficits indicate a stretched scar, which must be treated with resection and advancement of the medial

234 Patients with non-Hodgkin lymphoma (NHL) who are treated with rituximab may develop resistant disease

235 The patient being treated with rituximab was diagnosed postmortem an

236 cells (BMSCs) from WT and Col6alpha2-KO mice were treated with rmTNFalpha protein, the Col6alpha2-KO

237 ice infected with the T. cruzi Brazil strain were treated with RvD1.

238 Infarcted mice were treated with saline or BNP for 10 days.

239 Subjects with periodontitis were treated with scaling and root planing (SRP).

240 hegmatogenous retinal detachments (RRDs) can be treated with scleral buckle (SB), pars plana vitrecto

241 c human xenograft LNCaP tumours in SCID mice were treated with SDT using the systemically-administere

242 Advanced gastric cancer is treated with sequential lines of chemotherapy, starti

243 use disorder, and ongoing injection drug use were treated with sofosbuvir-velpatasvir for 12-weeks an

244 , patients with anaplastic thyroid carcinoma were treated with spartalizumab, a humanized monoclonal

245 ivity-based estimates of connectivity should be treated with special caution in strongly connected ne

246 ts, an equal number of eyes (19 in each arm) were treated with standard-fluence and reduced-fluence P

247 Patients were treated with steroid monotherapy (28.9% of cases),

248 Most patients (86%) were treated with steroids.

249 In this study, C57Bl/6 mice were treated with subcutaneous pellets containing vehicl

250 alivary gland mucoepidermoid carcinoma (MEC) are treated with surgery and radiotherapy, as current sy

251 nts with a chin up or chin down position can be treated with surgery on the vertical recti and/or obl

252 Non-early operable gastric cancer is treated with surgery, which should include D2 lymphad

253 2D6 in 1,309 patients with breast cancer who were treated with tamoxifen and were diagnosed from 2005

254 While patients with this disease can be treated with targeted antiendocrine agents, drug resi

255 Mice fed omega3-rich or omega6-rich diets were treated with TCDD and injected subcutaneously with

256 al cell line and four lung cancer cell lines were treated with TGF-beta.

257 ally identified cell types and that patients were treated with thalidomide rather than current therap

258 ing moderately Lewis basic functional groups are treated with the chiral solvating agent (CSA) Lambda

259 A horizontal face turn can be treated with the augmented Kestenbaum procedure, whil

260 al, we found that children whose mothers had been treated with the drug had higher prevalence of macr

261 ed with isoniazid only, while the second one was treated with the combination of RUTI vaccine and iso

262 Rabbits were treated with the beta3 AR agonists CL316,243 or ASP

263 i (soybean, green bean, cotton, and cabbage) were treated with the biopesticide AfMNPV baculovirus in

264 WT and Nod2(-/-) mice were treated with the carcinogen dimethylbenz[a]anthrace

265 CDC PRA+], C1q+) heart transplant candidates were treated with the combination of belatacept and PI t

266 e associations were disrupted when parasites were treated with the demethylation activator ascorbic a

267 een shown to rescue damaged cells, the cells were treated with the FDA-approved poloxamer 188 (P188).

268 when freshly excised human surgical samples were treated with the fluorescent silica nanoparticles n

269 n of HtrA1 activity in patients with AMD who were treated with the HtrA1-blocking Fab fragment.

270 stablishment of autoimmune myocarditis, mice were treated with the immunoproteasome inhibitor ONX 091

271 Mice with a fibrotic HCC were treated with the IRE1alpha-inhibitor 4mu8C, which r

272 otein levels significantly reduced when mice were treated with the JAK-2 inhibitor ruxolitinib (P < 0

273 Human orbital fibroblasts (OFs) were treated with the pro-scarring cytokine, transformin

274 Infected mice remained naive or were treated with the reverse transcriptase (RT) inhibit

275 Group 2 (n=30) were treated with the same schedule and had sparse dolut

276 Here, Akita mice, type 1 diabetic model, were treated with the visual pigment chromophore, 9-cis-

277 increasing number of patients with COVID-19 are treated with these agents and more evidence accumula

278 with chronic rheumatic diseases continue to be treated with these drugs.

279 of linezolid and daptomycin in patients who were treated with these antibiotics.

280 ears or older with acute ischemic stroke who were treated with tissue plasminogen activator, shorter

281 When a difluoro complex LPt(IV)F(2)(Ar)(py) is treated with TMS-X (TMS = trimethylsilyl; X= NMe(2),

282 Given these results, the patient was treated with tofacitinib, a JAK inhibitor, leading t

283 She was treated with topical antibiotics and achieved satisf

284 The 34 367 patients (55.9%) who were treated with tPA and had door-to-needle times of lo

285 minished when B16-F1 cell-inoculated animals were treated with trolox, nifedipine, or the adenosine r

286 isms of TSLP-mediated type 2 responses, mice were treated with TSLP and antigen to evaluate cellular

287 Therefore, she was treated with two trans-Tenon's retrobulbar injection

288 rative cohort outcome study, 66 patients who were treated with two iStent inject(R) devices were incl

289 teroidetes to Firmicutes were more likely to be treated with UDCA (Fisher's exact test p = 0.0178) th

290 Patients were treated with up to eight courses of the hyper-CVAD

291 HPDL cells were treated with various doses of poly I:C, a TLR3 acti

292 ive breast cancer cell line (MDA-MB-231-luc) were treated with varying concentrations of chemotherape

293 3) and 1.5% once daily (15 [50%] of 30) than were treated with vehicle (one [3%] of 32).

294 Mice were treated with vehicle or combined serine/threonine-p

295 Transplanted mice were treated with vehicle or di-n-butyl-phthalate (DBP,

296 Eight controls were treated with vehicle.

297 es were reduced in the field more when plots were treated with verbenone dispensers (SPLAT) co-deploy

298 Patients were treated with vitamin K antagonists (48.4%), parente

299 2 patients (1 with VSR, 1 with SRF); others were treated with weight loss and acetazolamide alone.

300 However, when MM6 cells were treated with zymosan or LPS during differentiation